Trial Profile
A study of entecavir to evaluate the relationship between adherence rates and hepatitis B (HBV) DNA levels in patients with chronic hepatitis B
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 17 Dec 2015
Price :
$35
*
At a glance
- Drugs Entecavir (Primary)
- Indications Hepatitis B
- Focus Therapeutic Use
- 17 Dec 2015 New trial record